Literature DB >> 19292868

Novel genes in cell cycle control and lipid metabolism with dynamically regulated binding sites for sterol regulatory element-binding protein 1 and RNA polymerase II in HepG2 cells detected by chromatin immunoprecipitation with microarray detection.

Mehdi Motallebipour1, Stefan Enroth, Tanel Punga, Adam Ameur, Christoph Koch, Ian Dunham, Jan Komorowski, Johan Ericsson, Claes Wadelius.   

Abstract

Sterol regulatory element-binding proteins 1 and 2 (SREBP-1 and SREBP-2) are important regulators of genes involved in cholesterol and fatty acid metabolism, but have also been implicated in the regulation of the cell cycle and have been associated with the pathogenesis of type 2 diabetes, atherosclerosis and obesity, among others. In this study, we aimed to characterize the binding sites of SREBP-1 and RNA polymerase II through chromatin immunoprecipitation and microarray analysis in 1% of the human genome, as defined by the Encyclopaedia of DNA Elements consortium, in a hepatocellular carcinoma cell line (HepG2). Our data identified novel binding sites for SREBP-1 in genes directly or indirectly involved in cholesterol metabolism, e.g. apolipoprotein C-III (APOC3). The most interesting biological findings were the binding sites for SREBP-1 in genes for host cell factor C1 (HCFC1), involved in cell cycle regulation, and for filamin A (FLNA). For RNA polymerase II, we found binding sites at classical promoters, but also in intergenic and intragenic regions. Furthermore, we found evidence of sterol-regulated binding of SREBP-1 and RNA polymerase II to HCFC1 and FLNA. From the results of this work, we infer that SREBP-1 may be involved in processes other than lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19292868     DOI: 10.1111/j.1742-4658.2009.06914.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

1.  Impaired postprandial lipemic response in chronic kidney disease.

Authors:  Jeffrey M Saland; Lisa M Satlin; Jeanna Zalsos-Johnson; Serge Cremers; Henry N Ginsberg
Journal:  Kidney Int       Date:  2016-05-07       Impact factor: 10.612

2.  Two polypyrimidine tracts in the nitric oxide synthase 2 gene: similar regulatory sequences with different properties.

Authors:  Mehdi Motallebipour; Alvaro Rada-Iglesias; Gunnar Westin; Claes Wadelius
Journal:  Mol Biol Rep       Date:  2009-08-08       Impact factor: 2.316

Review 3.  Targeting SREBP-1-driven lipid metabolism to treat cancer.

Authors:  Deliang Guo; Erica Hlavin Bell; Paul Mischel; Arnab Chakravarti
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.

Authors:  Yiyi Sun; Zhihe Zang; Xiaohong Xu; Zhonglin Zhang; Ling Zhong; Wang Zan; Yan Zhao; Lin Sun
Journal:  Int J Mol Sci       Date:  2010-03-31       Impact factor: 5.923

5.  An Untargeted Metabolomics Approach to Investigate the Metabolic Modulations of HepG2 Cells Exposed to Low Doses of Bisphenol A and 17β-Estradiol.

Authors:  Nicolas J Cabaton; Nathalie Poupin; Cécile Canlet; Marie Tremblay-Franco; Marc Audebert; Jean-Pierre Cravedi; Anne Riu; Fabien Jourdan; Daniel Zalko
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-25       Impact factor: 5.555

6.  Molecular Cloning, Characterization, and Expression Regulation of Acyl-CoA Synthetase 6 Gene and Promoter in Common Carp Cyprinus carpio.

Authors:  Dizhi Xie; Zijie He; Yewei Dong; Zhiyuan Gong; Guoxing Nie; Yuanyou Li
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

Review 7.  Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer.

Authors:  Qiushi Zhao; Xingyu Lin; Guan Wang
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

8.  Development of an immune-related prognostic index associated with hepatocellular carcinoma.

Authors:  Bo Hu; Xiao-Bo Yang; Xin-Ting Sang
Journal:  Aging (Albany NY)       Date:  2020-03-19       Impact factor: 5.955

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.